Allergan is trying to find 52,000 women with Biocell® breast implants that were recalled in July 2019 due to an increased risk of cancer.
Two women with cancer linked to their recalled breast implants have filed a class action lawsuit in California.
Two women have filed a class action lawsuit accusing Allergan of selling dangerous textured breast implants that can cause cancer.
In a major reversal, the FDA has asked Allergan to recall BIOCELL® textured breast implants in the U.S. after finding 24 more deaths and a 6-fold increased risk of ALCL, a rare but potentially deadly cancer.
Allergan has recalled all textured breast implants in Canada after dozens of women developed a rare cancer called Anaplastic Large Cell Lymphoma (ALCL).
Silicone breast implants with a textured shell are associated with a 400-fold increased risk of a rare cancer compared to smooth silicone breast implants, according to a study in JAMA Oncology.
Health officials in Australia reported 56 cases of Anaplastic Large-Cell Lymphoma (ALCL) in woman with breast implants, including 3 deaths since 2007.
The FDA has confirmed that breast implants can cause a rare type of non-Hodgkin's lymphoma. Textured breast implants are also more likely to cause cancer than smooth-surface breast implants.
Two lawsuits have been filed in California by women who got sick when their Mentor MemoryGel silicone breast implants leaked.